but retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide for weight loss: Study
Description
But more alarmingly, the risk of 'undisclosed ingredients' or even contaminants is very real with unregulated products

Liraglutide compromises pancreatic cell function in a humanized mouse model
Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2

However, extensive cardiovascular outcome trials have demonstrated that GLP-1 receptor agonists are safe and may even reduce cardiovascular risk

One active ingredient can be licensed under multiple brand names when the manufacturer pursues different FDA indications or when generic manufacturers enter the market after patent expiration
